02/14/2025 12:04 PM | EcoR1 Capital, LLC (Filed by) Eton Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025 6:15 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2025 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 3:22 PM | Eton Pharmaceuticals (Issuer) RIEDEL NORBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 3:23 PM | Adams Jennifer McKie (Reporting) Eton Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2024 6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 3:30 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 3:27 PM | Eton Pharmaceuticals (Filer)
| Form 424B5 | |
12/09/2024 4:11 PM | Erdogan-Trinkaus Ipek (Reporting) Eton Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ETON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eton Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
12/03/2024 6:00 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/25/2024 6:00 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:05 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 3:05 PM | Eton Pharmaceuticals (Issuer) Opaleye Management Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 5:34 PM | Eton Pharmaceuticals (Issuer) Opaleye Management Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:19 PM | Eton Pharmaceuticals (Issuer) Krempa David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 5:30 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 6:31 PM | Eton Pharmaceuticals (Issuer) Opaleye Management Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:05 PM | Eton Pharmaceuticals (Issuer) Opaleye Management Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/12/2024 3:05 PM | Eton Pharmaceuticals (Subject) Opaleye Management Inc. (Filed by)
| Form SC 13G/A | |
08/08/2024 3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:16 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:17 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:25 PM | Eton Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024 6:15 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 6:00 AM | Eton Pharmaceuticals (Subject) HARROW, INC. (Filed by) HARROW, INC. (Filed by) HARROW, INC. (Filed by)
| Form SC 13D/A | |
04/26/2024 3:21 PM | Eton Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024 3:22 PM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 3:24 PM | Eton Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/22/2024 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 5:55 AM | Eton Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |